nodes	percent_of_prediction	percent_of_DWPC	metapath
Cimetidine—FMO1—nervous system—Gilles de la Tourette syndrome	0.0393	0.0567	CbGeAlD
Cimetidine—FMO1—central nervous system—Gilles de la Tourette syndrome	0.0379	0.0545	CbGeAlD
Cimetidine—FMO3—nervous system—Gilles de la Tourette syndrome	0.034	0.049	CbGeAlD
Cimetidine—FMO3—central nervous system—Gilles de la Tourette syndrome	0.0327	0.0471	CbGeAlD
Cimetidine—HRH2—nervous system—Gilles de la Tourette syndrome	0.0303	0.0436	CbGeAlD
Cimetidine—FMO1—brain—Gilles de la Tourette syndrome	0.0301	0.0433	CbGeAlD
Cimetidine—HRH2—central nervous system—Gilles de la Tourette syndrome	0.0291	0.042	CbGeAlD
Cimetidine—FMO3—brain—Gilles de la Tourette syndrome	0.026	0.0374	CbGeAlD
Cimetidine—SLC22A7—brain—Gilles de la Tourette syndrome	0.0237	0.0341	CbGeAlD
Cimetidine—SLC47A1—nervous system—Gilles de la Tourette syndrome	0.0234	0.0336	CbGeAlD
Cimetidine—HRH2—brain—Gilles de la Tourette syndrome	0.0231	0.0333	CbGeAlD
Cimetidine—SLC22A6—brain—Gilles de la Tourette syndrome	0.0229	0.033	CbGeAlD
Cimetidine—SLC47A1—central nervous system—Gilles de la Tourette syndrome	0.0225	0.0324	CbGeAlD
Cimetidine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.0207	0.0678	CbGpPWpGaD
Cimetidine—SLC22A1—nervous system—Gilles de la Tourette syndrome	0.0195	0.0281	CbGeAlD
Cimetidine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.0193	0.0632	CbGpPWpGaD
Cimetidine—SLC22A1—central nervous system—Gilles de la Tourette syndrome	0.0188	0.027	CbGeAlD
Cimetidine—SLC22A3—nervous system—Gilles de la Tourette syndrome	0.0186	0.0268	CbGeAlD
Cimetidine—SLC22A3—central nervous system—Gilles de la Tourette syndrome	0.0179	0.0258	CbGeAlD
Cimetidine—SLC22A8—nervous system—Gilles de la Tourette syndrome	0.0179	0.0258	CbGeAlD
Cimetidine—SLC47A1—brain—Gilles de la Tourette syndrome	0.0179	0.0257	CbGeAlD
Cimetidine—SLC22A8—central nervous system—Gilles de la Tourette syndrome	0.0173	0.0248	CbGeAlD
Cimetidine—SLC22A5—midbrain—Gilles de la Tourette syndrome	0.0165	0.0237	CbGeAlD
Cimetidine—SLC22A4—brain—Gilles de la Tourette syndrome	0.0156	0.0225	CbGeAlD
Cimetidine—HRH2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0151	0.0492	CbGpPWpGaD
Cimetidine—SLC22A1—brain—Gilles de la Tourette syndrome	0.0149	0.0215	CbGeAlD
Cimetidine—SLC22A3—brain—Gilles de la Tourette syndrome	0.0142	0.0205	CbGeAlD
Cimetidine—SLC22A8—brain—Gilles de la Tourette syndrome	0.0137	0.0197	CbGeAlD
Cimetidine—HRH2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0128	0.042	CbGpPWpGaD
Cimetidine—HRH2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0125	0.0408	CbGpPWpGaD
Cimetidine—HRH2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0116	0.038	CbGpPWpGaD
Cimetidine—CYP2E1—nervous system—Gilles de la Tourette syndrome	0.011	0.0159	CbGeAlD
Cimetidine—HRH2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0108	0.0353	CbGpPWpGaD
Cimetidine—CYP2E1—central nervous system—Gilles de la Tourette syndrome	0.0106	0.0153	CbGeAlD
Cimetidine—HRH2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0105	0.0343	CbGpPWpGaD
Cimetidine—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.0104	0.034	CbGpPWpGaD
Cimetidine—SLC22A5—brain—Gilles de la Tourette syndrome	0.0104	0.0149	CbGeAlD
Cimetidine—CYP2C8—brain—Gilles de la Tourette syndrome	0.01	0.0144	CbGeAlD
Cimetidine—HRH2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00976	0.0319	CbGpPWpGaD
Cimetidine—SLC22A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.00967	0.0316	CbGpPWpGaD
Cimetidine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00888	0.0128	CbGeAlD
Cimetidine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.00874	0.0126	CbGeAlD
Cimetidine—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00859	0.0281	CbGpPWpGaD
Cimetidine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.00855	0.0123	CbGeAlD
Cimetidine—CYP2E1—brain—Gilles de la Tourette syndrome	0.00844	0.0122	CbGeAlD
Cimetidine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.00842	0.0121	CbGeAlD
Cimetidine—HRH2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00813	0.0266	CbGpPWpGaD
Cimetidine—ABCB1—midbrain—Gilles de la Tourette syndrome	0.00765	0.011	CbGeAlD
Cimetidine—SLC22A2—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.0072	0.0236	CbGpPWpGaD
Cimetidine—HRH2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00684	0.0224	CbGpPWpGaD
Cimetidine—SLC22A1—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.00671	0.022	CbGpPWpGaD
Cimetidine—CYP2D6—brain—Gilles de la Tourette syndrome	0.00668	0.00962	CbGeAlD
Cimetidine—ABCB1—nervous system—Gilles de la Tourette syndrome	0.00629	0.00906	CbGeAlD
Cimetidine—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.00605	0.00872	CbGeAlD
Cimetidine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00596	0.0195	CbGpPWpGaD
Cimetidine—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00531	0.0174	CbGpPWpGaD
Cimetidine—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00482	0.0158	CbGpPWpGaD
Cimetidine—ABCB1—brain—Gilles de la Tourette syndrome	0.00481	0.00692	CbGeAlD
Cimetidine—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00449	0.0147	CbGpPWpGaD
Cimetidine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00448	0.0146	CbGpPWpGaD
Cimetidine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00405	0.0132	CbGpPWpGaD
Cimetidine—SLC47A1—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.0039	0.0128	CbGpPWpGaD
Cimetidine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00338	0.0111	CbGpPWpGaD
Cimetidine—FMO3—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00328	0.0107	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00303	0.00991	CbGpPWpGaD
Cimetidine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00282	0.00921	CbGpPWpGaD
Cimetidine—SLC22A4—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00271	0.00885	CbGpPWpGaD
Cimetidine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00263	0.00859	CbGpPWpGaD
Cimetidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00248	0.00811	CbGpPWpGaD
Cimetidine—SLC22A11—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00241	0.00789	CbGpPWpGaD
Cimetidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00241	0.00787	CbGpPWpGaD
Cimetidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00224	0.00733	CbGpPWpGaD
Cimetidine—SLC22A7—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00219	0.00716	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—HDC—Gilles de la Tourette syndrome	0.00217	0.00709	CbGpPWpGaD
Cimetidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00212	0.00694	CbGpPWpGaD
Cimetidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00206	0.00674	CbGpPWpGaD
Cimetidine—SLC22A3—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00204	0.00668	CbGpPWpGaD
Cimetidine—SLC22A5—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00203	0.00665	CbGpPWpGaD
Cimetidine—SLC47A1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00198	0.00649	CbGpPWpGaD
Cimetidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00192	0.00628	CbGpPWpGaD
Cimetidine—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00184	0.00602	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00178	0.00583	CbGpPWpGaD
Cimetidine—HRH2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00162	0.00529	CbGpPWpGaD
Cimetidine—SLC22A2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00158	0.00517	CbGpPWpGaD
Cimetidine—HRH2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00157	0.00513	CbGpPWpGaD
Cimetidine—HRH2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00157	0.00513	CbGpPWpGaD
Cimetidine—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00154	0.00502	CbGpPWpGaD
Cimetidine—SLC22A1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00147	0.00481	CbGpPWpGaD
Cimetidine—HRH2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00146	0.00478	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—HDC—Gilles de la Tourette syndrome	0.0014	0.00457	CbGpPWpGaD
Cimetidine—SLC22A4—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00138	0.0045	CbGpPWpGaD
Cimetidine—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00134	0.0044	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—HDC—Gilles de la Tourette syndrome	0.00134	0.00438	CbGpPWpGaD
Cimetidine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00128	0.00419	CbGpPWpGaD
Cimetidine—SLC22A11—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00123	0.00401	CbGpPWpGaD
Cimetidine—SLC22A2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00121	0.00396	CbGpPWpGaD
Cimetidine—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00119	0.0039	CbGpPWpGaD
Cimetidine—SLC22A1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00113	0.00369	CbGpPWpGaD
Cimetidine—SLC22A7—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00111	0.00364	CbGpPWpGaD
Cimetidine—SLC22A3—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00104	0.00339	CbGpPWpGaD
Cimetidine—SLC22A5—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00103	0.00338	CbGpPWpGaD
Cimetidine—HRH2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00102	0.00335	CbGpPWpGaD
Cimetidine—SLC22A8—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000935	0.00306	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000913	0.00299	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000887	0.0029	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—HDC—Gilles de la Tourette syndrome	0.000877	0.00287	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.000875	0.00286	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00083	0.00271	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000826	0.0027	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000816	0.00267	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000805	0.00263	CbGpPWpGaD
Cimetidine—SLC22A6—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00078	0.00255	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00075	0.00245	CbGpPWpGaD
Cimetidine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00065	0.00213	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000635	0.00208	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—HDC—Gilles de la Tourette syndrome	0.000634	0.00207	CbGpPWpGaD
Cimetidine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000606	0.00198	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000579	0.00189	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—HDC—Gilles de la Tourette syndrome	0.000549	0.0018	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000525	0.00172	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00049	0.0016	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—HDC—Gilles de la Tourette syndrome	0.00049	0.0016	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000478	0.00156	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000476	0.00156	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000451	0.00147	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—HDC—Gilles de la Tourette syndrome	0.000447	0.00146	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000443	0.00145	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.000382	0.00125	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000355	0.00116	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00031	0.00102	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.000295	0.000964	CbGpPWpGaD
